-
New guidance on safety monitoring of medicines in children
New guidance on safety monitoring of medicines in children
-
New guidance on safety monitoring of medicines in children
New guidance on safety monitoring of medicines in children
Good pharmacovigilance practice (GVP) chapter provides a holistic view of paediatric pharmacovigilance and guidance on best use of existing tools and processes to address the specific needs and challenges of safety monitoring of medicines used in children.
-
Industry stakeholder meeting on 24 September
Industry stakeholder meeting on 24 September
-
Industry stakeholder meeting on 24 September
Industry stakeholder meeting on 24 September
A report from the meeting outlines how the European medicines regulatory network is preparing for Brexit, including EMA’s relocation and business continuity planning.
-
EMA's workshop on availability of medicines
EMA's workshop on availability of medicines
-
EMA's workshop on availability of medicines
EMA's workshop on availability of medicines
The EMA-Heads of Medicines Agencies task force on availability of authorised human and veterinary medicines organised a stakeholder workshop on 8-9 November 2018 to discuss how to better address potential problems with the supply of medicines and avoid shortages in the EU.
-
Shaping regulatory science to 2025
Shaping regulatory science to 2025
-
Shaping regulatory science to 2025
Shaping regulatory science to 2025
EMA held a multi-stakeholder workshop on 24 October 2018 to gather initial thoughts on the key areas for human medicines to be covered in EMA’s regulatory science strategy to 2025.
